Cite
APA Citation
Verstovsek, S., Odenike, O., Singer, J., Granston, T., Al-Fayoumi, S., & Deeg, H. (2016). phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies. Journal of hematology & oncology, 9(1), 1–12. http://access.bl.uk/ark:/81055/vdc_100080954858.0x000081